Complete Guide to Medical Marijuana Laws in All 41 Legal States
- 41 U.S. states have legalized medical cannabis, accounting for over 80% of the country, with extensive variations in legalization dates, possession limits, qualifying conditions, tax rates, and dispensary operations across states.
- Possession limits and cultivation rights differ significantly among states, ranging from patient home-grow models (e.g., Alaska, Maine) to strict no-home-grow policies (e.g., Florida, Pennsylvania), with some states using supply or dosage-based systems rather than simple weight limits.
- Taxation on medical cannabis varies widely, from states with specific excise taxes and privilege taxes (e.g., Alabama, Oklahoma, Mississippi) to those exempting medical cannabis from retail sales or adult-use taxes (e.g., California, Illinois, Colorado), reflecting different approaches to medical patient affordability.
- Qualifying medical conditions across states generally include cancer, chronic pain, PTSD, epilepsy, and other severe or debilitating illnesses, but some states allow broad physician discretion while others have closed lists; program rollouts have been influenced by regulatory delays, federal enforcement concerns, and evolving legal frameworks.
41 states have legalized the medical use of cannabis, representing over 80% of the entire United States. Below is a breakdown of all 41 states, including details on when the state legalized the medicine, when the first dispensary opened, possession limits and more.
Year legalized: 2021.
Year first dispensary opened: The first dispensary is expected
Possession limits: up to 70 daily dosages for a registered patient; usable forms exclude raw flower, smoking, vaping, and standard edibles.
Tax rate: Alabama’s statute imposes a 9% excise tax on retail medical-cannabis sales, plus an annual medical-cannabis privilege tax.
Qualifying conditions: closed list, including cancer-related cachexia or nausea, depression or anxiety related to terminal illness, epilepsy, panic disorder, PTSD, autism spectrum disorder, MS/spinal-cord spasticity, terminal illness, Tourette syndrome, and chronic or intractable pain when conventional and opiate therapy is ineffective or contraindicated.
Anything else notable: the program has been unusually delayed by licensing litigation.
Year legalized: 1998.
Year first dispensary opened: none; Alaska’s medical law did not create medical dispensaries, and later adult-use retail began separately in 2016.
Possession limits: generally 1 ounce usable cannabis and 6 plants, not more than 3 mature.
Tax rate: no medical-dispensary tax structure applies because there is no medical-dispensary system.
Qualifying conditions: classic closed debilitating-condition list, including cancer, glaucoma, HIV/AIDS, chronic pain, and seizure/spasticity-related conditions.
Anything else notable: Alaska remains one of the clearest examples of a patient/caregiver-plus-home-grow model rather than a dedicated medical-retail model.
Year legalized: 2010.
Year first dispensary opened: 2012.
Possession limits: 2.5 ounces of usable marijuana; if the patient is cultivation-authorized because the residence is far from a dispensary, up to 12 plants.
Tax rate: no medical-specific excise was identified in the reviewed sources; Arizona’s adult-use excise does not apply to medical sales.
Qualifying conditions: closed list, including cancer, glaucoma, HIV, AIDS, hepatitis C, ALS, Crohn’s disease, agitation of Alzheimer’s disease, and severe pain, severe nausea, seizures, persistent muscle spasms, PTSD, and other department-added debilitating conditions.
Anything else notable: Arizona still preserves a meaningful medical advantage over adult-use through higher possession limits and cultivation access for some patients.
Year legalized: 2016.
Year first dispensary opened: 2019; the Arkansas Department of Health says the first dispensary opened on May 10, 2019.
Possession limits: 2.5 ounces every 14 days; no home cultivation.
Tax rate: Arkansas has ordinary sales tax on retail sales and a 4% special privilege tax on transfers of medical cannabis.
Qualifying conditions: closed list, including cancer, glaucoma, HIV/AIDS, hepatitis C, ALS, Tourette’s syndrome, Crohn’s disease, ulcerative colitis, PTSD, severe arthritis, fibromyalgia, peripheral neuropathy, intractable pain, severe nausea, seizures, severe muscle spasms, Alzheimer’s disease, and cachexia.
Anything else notable: Arkansas allows visiting-patient cards, uses a strict registry-card model, and has one of the clearer official FAQ systems for conditions and limits.
Year legalized: 1996.
Year first dispensary opened: for a regulated state-licensed market, 2018; collectives and dispensaries existed much earlier in a legal gray area after Proposition 215 and later legislation.
Possession limits: California’s statutory baseline is 8 ounces of dried cannabis and 6 mature or 12 immature plants, but patients may exceed that with a physician recommendation if medically necessary.
Tax rate: California imposes a 15% cannabis excise tax on retail sales; however, qualified medical purchasers with a valid Medical Marijuana Identification Card are exempt from sales tax on medicinal cannabis.
Qualifying conditions: effectively broad physician discretion under the Compassionate Use Act for serious or chronic illnesses where cannabis provides relief.
Anything else notable: California remains highly local-control dependent, and the distinction between a physician recommendation and a county-issued MMIC still matters for tax treatment.
Year legalized: 2000.
Year first dispensary opened: dispensaries existed before the 2010 regulatory law; the licensed system was phased in during 2010–2011.
Possession limits: generally 2 ounces usable cannabis and home cultivation, with medical exceptions and extended-plant-count procedures for some patients.
Tax rate: Colorado’s adult-use marijuana excise and special retail marijuana sales taxes do not apply to medical cannabis; ordinary sales-tax treatment generally governs.
Qualifying conditions: closed but broad list, including cancer, glaucoma, HIV/AIDS, cachexia, severe pain, severe nausea, seizures, persistent muscle spasms, PTSD, and autism-spectrum disorder.
Anything else notable: Colorado’s medical system still matters because patients can seek higher plant-count authority and other medical-only protections.
Year legalized: 2012.
Year first dispensary opened: 2014.
Possession limits: form- and certification-based; the modern system is practitioner-linked and usually summarized as a monthly supply model rather than a simple ounce cap.
Tax rate: no medical-specific cannabis excise was identified in the reviewed sources.
Qualifying conditions: broad adult access through practitioner certification, with a more defined condition list for minors.
Year legalized: 2011.
Year first dispensary opened: 2015.
Possession limits: generally up to 6 ounces for registered patients.
Tax rate: Delaware has no general sales tax, and no medical-specific patient retail tax was identified in the reviewed materials.
Qualifying conditions: Delaware now allows broader practitioner discretion, including certification for any diagnosed medical condition or disease if a health care practitioner determines the patient may receive therapeutic or palliative benefit. Patients 65 and older may self-certify.
Anything else notable: Delaware took years to launch because of federal-enforcement concerns during the early rollout period, but the program has since shifted away from a strictly limited qualifying-condition model.
Year legalized: comprehensive constitutional amendment in 2016, building on more limited 2014 and 2016 laws.
Year first dispensary opened: 2016 under the earlier limited framework.
Possession limits: Florida uses a physician-controlled supply model; smokable flower is ordinarily capped at 2.5 ounces per 35-day supply within the broader 70-day supply framework.
Tax rate: no distinct medical-cannabis retail excise was clearly identified in the reviewed sources.
Qualifying conditions: broad but still enumerated, including cancer, epilepsy, glaucoma, HIV/AIDS, PTSD, ALS, Crohn’s disease, Parkinson’s disease, multiple sclerosis, terminal conditions, and comparable debilitating conditions.
Anything else notable: Florida still does not allow home cultivation, which remains one of the central patient-rights flashpoints.
Year legalized: 2015 for low-THC oil; Georgia became a comprehensive medical-cannabis state in 2026 when SB 220 expanded the program.
Year first dispensary opened: 2023.
Possession limits: Georgia historically allowed 20 fluid ounces of low-THC oil with a 5% THC cap; the 2026 bill moved to a 12,000 milligram THC cap at one time and expanded forms, including vaporization.
Tax rate: no separate medical-specific retail tax was clearly identified in the reviewed sources.
Qualifying conditions: closed list, including AIDS, Alzheimer’s disease, ALS, autism spectrum disorder, end-stage cancer with wasting or refractory nausea, Crohn’s disease, epidermolysis bullosa, intractable pain, mitochondrial disease, severe/end-stage MS or Parkinson’s disease, hospice status, severe peripheral neuropathy, adult PTSD, epilepsy or trauma-related seizure disorders, severe/end-stage sickle-cell disease, and severe Tourette syndrome.
Anything else notable: Georgia still relies on physician certification and a card system, with a five-year card and a $30 card fee shown on the public-health site; its 2026 reform is the single most important current change in this 41-state landscape.
Year legalized: 2000; dispensaries were added by later legislation in 2015.
Year first dispensary opened: 2017.
Possession limits: generally 4 ounces usable cannabis and home cultivation rights.
Tax rate: no clearly identified medical-specific cannabis excise was found in the reviewed materials.
Qualifying conditions: debilitating-condition list including cancer, glaucoma, HIV/AIDS, cachexia, severe pain, severe nausea, seizures, severe muscle spasms, lupus, epilepsy, and others.
Anything else notable: Hawaii has long been notable for out-of-state patient reciprocity and for preserving both home grow and regulated dispensary access.
Year legalized: 2013.
Year first dispensary opened: 2015.
Possession limits: 2.5 ounces every 14 days, with higher allotments possible when medically necessary; registered medical patients may cultivate up to five plants at home.
Tax rate: Illinois medical cannabis is taxed at the 1% pharmaceutical sales-tax rate, not the higher adult-use tax structure.
Qualifying conditions: broad qualifying-condition structure, including chronic pain, PTSD, cancer, HIV/AIDS, Crohn’s disease, multiple sclerosis, seizure disorders, and many others.
Anything else notable: Illinois is one of the most patient-favorable states in an adult-use market because medical status still produces meaningful tax and cultivation advantages.
Year legalized: 2023.
Year first dispensary opened: 2025.
Possession limits: Kentucky uses a 10-day and 30-day supply model. Public program materials state that a 30-day supply equals 112 grams raw plant material, 28 grams concentrate, or 3,900 milligrams THC-infused product; a 10-day supply equals 37.5 grams raw plant, 9.5 grams concentrate, or 1,300 milligrams THC-infused product.
Tax rate: Kentucky medical marijuana is exempt from sales and excise taxes.
Qualifying conditions: closed list, including all cancers, chronic or severe pain, epilepsy and other seizure disorders, multiple sclerosis and spasticity, chronic nausea, PTSD, Crohn’s disease, and terminal illness, among others.
Anything else notable: Kentucky allows visiting patients to possess and buy up to a 10-day supply, allows delivery, drive-thru and curbside access in program guidance, bars home grow, and charges a $25 application or renewal fee for cards.
Year legalized: 2016 is the modern workable law; state sources and MPP treat earlier versions as ineffective.
Year first dispensary opened: 2019.
Possession limits: Louisiana generally uses a 30-day supply model rather than a simple ounce cap.
Tax rate: no medical-specific retail tax was clearly identified in the reviewed materials.
Qualifying conditions: effectively broad physician discretion; Louisiana moved from a long statutory list toward a system where a recommending physician may approve any condition considered debilitating and within professional judgment.
Anything else notable: Louisiana remains distinctive because dispensing occurs through a tightly controlled pharmacy model rather than ordinary dispensaries.
Year legalized: 1999, with major later revisions in 2009–2011.
Year first dispensary opened: 2011.
Possession limits: Maine combines on-person possession protections with one of the nation’s strongest patient/caregiver cultivation models; the simple on-person cap has traditionally centered on 2.5 ounces, but practical legal access can be broader through cultivation and caregiver rules.
Tax rate: Maine taxes medical marijuana at 5.5% for most products and 8% for edibles.
Qualifying conditions: broad and now substantially physician-discretion driven.
Anything else notable: Maine’s caregiver system remains one of the most permissive and historically important in the country.
Year legalized: 2014.
Year first dispensary opened: 2017.
Possession limits: usually 120 grams of usable cannabis in 30 days or the equivalent amount in products, unless a certifying provider authorizes more.
Tax rate: no medical-specific retail tax is generally imposed on Maryland patients.
Qualifying conditions: relatively broad, with practitioner certification for severe conditions where other treatments have not been effective.
Anything else notable: Maryland’s medical market remained important even after adult-use legalization because registered patients keep tax and access advantages.
Year legalized: 2012.
Year first dispensary opened: 2015.
Possession limits: 10 ounces or a 60-day supply, with hardship cultivation available.
Tax rate: no medical-specific excise was identified; medical purchases are generally carved out from the adult-use tax stack.
Qualifying conditions: open physician-discretion model for debilitating conditions.
Anything else notable: Massachusetts remains notable for hardship home-grow approvals and its early integration of patient access with a formal dispensary structure.
Year legalized: 2008; state-licensed dispensary law in 2016.
Year first dispensary opened: 2018 in the licensed system.
Possession limits: 2.5 ounces usable cannabis and 12 plants for a patient; caregivers may hold additional plants for registered patients.
Tax rate: Michigan medical cannabis is generally subject to 6% sales tax and is exempt from the adult-use 10% excise tax.
Qualifying conditions: broad enumerated conditions plus physician certification.
Anything else notable: Michigan’s caregiver model still differentiates it from many peer states.
Year legalized: 2014.
Year first dispensary opened: 2015.
Possession limits: Minnesota uses a 90-day supply framework rather than a simple ounce cap.
Tax rate: no medical-specific retail excise was identified in the reviewed materials.
Qualifying conditions: broad but still program-defined, including intractable pain, PTSD, cancer, glaucoma, HIV/AIDS, Tourette syndrome, seizures, autism, obstructive sleep apnea, and more.
Anything else notable: flower arrived later than in most medical states, and the medical system still matters even after adult-use legalization because rules and patient access channels differ.
Year legalized: 2022 after the earlier voter initiative was invalidated.
Year first dispensary opened: 2023.
Possession limits: Mississippi uses MMCEUs, not just ounces. The program commonly caps patients at 24 MMCEUs per 30 days, with equivalency rules by product form.
Tax rate: Mississippi imposes a 7% medical-cannabis sales tax.
Qualifying conditions: closed list, including cancer, Parkinson’s disease, Huntington’s disease, muscular dystrophy, glaucoma, spastic quadriplegia, HIV/AIDS, hepatitis, ALS, Crohn’s disease, ulcerative colitis, sickle-cell anemia, Alzheimer’s disease agitation, autism with severe behaviors, chronic pain, and PTSD, among others.
Anything else notable: the state moved unusually fast once the legislature enacted the replacement program.
Year legalized: 2018.
Year first dispensary opened: 2020.
Possession limits: 6 ounces of dried-flower equivalent per 30 days; home cultivation is available to registered patients.
Tax rate: Missouri charges a 4% state tax on retail medical marijuana, and local governments may add local taxes.
Qualifying conditions: broad physician-discretion standard for a chronic, debilitating, or other medical condition, plus explicit examples such as cancer, epilepsy, intractable migraines, PTSD, and chronic pain.
Anything else notable: the combination of home cultivation and broad physician discretion has made Missouri one of the more patient-friendly medical states in the Midwest.
Year legalized: 2004; dispensary access was restored and clarified by the 2016 initiative.
Year first dispensary opened: licensed dispensaries began receiving approvals in 2018.
Possession limits: medical possession and cultivation rights exist, but plant and possession authorizations can be provider- and registry-specific; a simple public-facing summary is harder than in some states.
Tax rate: Montana imposes a 4% state tax on medical marijuana, with some counties adding a local-option tax of up to 3%.
Qualifying conditions: listed debilitating conditions, including cancer, glaucoma, HIV/AIDS, cachexia, severe chronic pain, seizures, and muscle spasms.
Anything else notable: Montana is a classic example of a medical program repeatedly narrowed and then re-expanded by legislation and ballot initiative.
Year legalized: 2024.
Year first dispensary opened: not yet, as of the sources reviewed; MPP said dispensaries were not yet licensed as of early 2026.
Possession limits: Nebraska’s 2024 initiative authorized possession, use, and acquisition of up to 5 ounces of cannabis for medical reasons.
Tax rate: unspecified in the materials reviewed.
Qualifying conditions: the public law and implementation materials were still being operationalized, and a full public-facing current condition list was not clear from the reviewed sources.
Anything else notable: Nebraska is still in implementation mode; emergency rules were in place and cultivation licensing had begun before retail dispensaries.
Year legalized: registry legislation in 2000–2001; the modern dispensary law passed in 2013.
Year first dispensary opened: 2015.
Possession limits: generally 2.5 ounces in a 14-day period, with home cultivation allowed if the patient lives far enough from a dispensary.
Tax rate: no distinct medical retail excise was clearly identified in the reviewed materials for patients.
Qualifying conditions: listed debilitating conditions, including cancer, glaucoma, HIV/AIDS, cachexia, severe pain, nausea, seizures, persistent muscle spasms, PTSD, and others.
Anything else notable: reciprocity for out-of-state patients has long been an important Nevada feature.
Year legalized: 2013.
Year first dispensary opened: 2016.
Possession limits: commonly summarized as 2 ounces usable cannabis in a 10-day period.
Tax rate: no medical-specific retail tax identified.
Qualifying conditions: statutory debilitating-condition list with later additions such as moderate-to-severe PTSD.
Anything else notable: New Hampshire historically had no home grow, making alternative treatment centers central to patient access.
Year legalized: 2010.
Year first dispensary opened: 2012.
Possession limits: up to 3 ounces in a 30-day period.
Tax rate: New Jersey phased its medical-sales tax down to 0%.
Qualifying conditions: broad medical list and practitioner discretion for chronic pain, anxiety, PTSD, cancer, glaucoma, migraines, opioid-use disorder, and many more.
Anything else notable: medical patients retain meaningful advantages over adult-use consumers, especially in pricing and access.
Year legalized: 2007.
Year first dispensary opened: 2010.
Possession limits: New Mexico has often used a 15-ounce per 90-day baseline in the medical program, with personal-production licenses available.
Tax rate: no clearly identified medical-specific excise was found in the reviewed materials.
Qualifying conditions: broad list with petition procedures and physician involvement.
Anything else notable: New Mexico was an early innovator in licensed production and continues to preserve strong reciprocity and home-grow pathways.
Year legalized: 2014.
Year first dispensary opened: 2016.
Possession limits: up to a 60-day supply, or up to 3 ounces of cannabis and 24 grams of concentrate, whichever is greater.
Tax rate: no medical-specific retail tax was clearly identified in the reviewed materials.
Qualifying conditions: New York has moved toward a broad physician-discretion model rather than a rigid enumerated list.
Anything else notable: New York now allows home cultivation for registered medical patients, subject to program rules.
Year legalized: 2016.
Year first dispensary opened: 2019.
Possession limits: supply-based; North Dakota’s program has used product-form limits rather than a single simple cap.
Tax rate: no medical-specific retail tax was clearly identified in the reviewed materials.
Qualifying conditions: listed debilitating conditions with petition procedures.
Anything else notable: North Dakota does not allow home cultivation, though the program has expanded product access, including cannabis-infused edible products.
Year legalized: 2016.
Year first dispensary opened: 2019.
Possession limits: Ohio uses a 90-day supply model linked to product form and THC/concentrate calculations rather than a simple ounce cap.
Tax rate: no medical-specific retail excise was clearly identified in the reviewed materials.
Qualifying conditions: listed conditions include chronic and severe pain, PTSD, cancer, epilepsy, multiple sclerosis, sickle-cell disease, Parkinson’s disease, and others.
Anything else notable: the medical system remains distinct even after adult-use legalization because patient rules and supply mechanisms differ.
Year legalized: 2018.
Year first dispensary opened: 2018.
Possession limits: 3 ounces on the person, 8 ounces at home, 1 ounce of concentrates, 72 ounces of edibles, and 6 mature plus 6 seedling plants.
Tax rate: Oklahoma imposes a 7% excise tax on medical marijuana, in addition to ordinary sales tax.
Qualifying conditions: Oklahoma is the archetypal open-physician-discretion state; no fixed qualifying-condition list is required.
Anything else notable: no other major medical state moved from enactment to storefront access as fast as Oklahoma.
Year legalized: 1998.
Year first dispensary opened: 2014 in the state-licensed medical dispensary system.
Possession limits: Oregon’s OMMP uses comparatively generous possession and plant allowances and continues to preserve home-grow rights.
Tax rate: no medical-specific retail tax identified.
Qualifying conditions: listed debilitating conditions plus state petition procedures.
Anything else notable: Oregon was among the earliest states to regularize medical dispensaries after years of informal arrangements.
Year legalized: 2016.
Year first dispensary opened: 2018.
Possession limits: Pennsylvania uses a 30-day supply model; smoking remains prohibited, though dry leaf may be sold for vaporization.
Tax rate: Pennsylvania’s best-known medical tax is a 5% gross receipts tax on grower/processor sales to dispensaries, not a standard patient-facing retail excise.
Qualifying conditions: broad list including cancer, epilepsy, HIV/AIDS, PTSD, multiple sclerosis, neuropathy, opioid-use disorder, anxiety-related additions, and chronic pain.
Anything else notable: home grow remains prohibited, which is one of the most contested gaps in Pennsylvania’s framework.
Year legalized: 2006.
Year first dispensary opened: 2013.
Possession limits: 2.5 ounces and home-cultivation rights for cardholders, with higher at-home storage structures in some circumstances.
Tax rate: Rhode Island applies the 7% state sales tax to medical marijuana, along with a 4% compassion-center surcharge.
Qualifying conditions: broad debilitating-condition structure with petition options.
Anything else notable: Rhode Island’s compassion-center rollout was repeatedly delayed by federal-enforcement concerns and later statutory revisions.
Year legalized: 2020.
Year first dispensary opened: 2022.
Possession limits: generally 3 ounces, with practitioner authority for higher amounts in some cases; home cultivation is limited and hinges on location/access criteria.
Tax rate: no medical-specific retail excise was clearly identified in the reviewed materials.
Qualifying conditions: listed serious debilitating conditions.
Anything else notable: South Dakota’s medical law and its failed adult-use effort moved on sharply different tracks, making the medical program the state’s operative cannabis-access regime.
Year legalized: 2015 under the Compassionate Use Act; important expansion in 2025 under HB 46.
Year first dispensary opened: 2018.
Possession limits: Texas continues to use a product- and prescription-based model rather than flower or home grow. After HB 46, reviewed summaries describe up to 10 mg THC per dose and a package cap of 1 gram THC, while still prohibiting raw flower.
Tax rate: no medical-specific retail tax was clearly identified in the reviewed sources.
Qualifying conditions: Texas DPS now publicly lists ALS, autism, cancer, Crohn’s disease and other IBD, chronic pain, epilepsy, incurable neurodegenerative disease, multiple sclerosis, PTSD, seizure disorder, spasticity, terminal illness or hospice/palliative status, and traumatic brain injury.
Anything else notable: HB 46 expanded delivery forms to include patches, suppositories, lotions, and certain pulmonary-inhalation products, required a total of 15 licenses, and confirmed that patients do not register with the state or pay a patient fee.
Year legalized: 2018.
Year first dispensary opened: 2020.
Possession limits: Utah uses a tightly regulated 30-day supply model with separate caps for unprocessed cannabis and total THC in other dosage forms.
Tax rate: no medical-specific retail excise was clearly identified in the reviewed materials.
Qualifying conditions: broad but enumerated, including HIV, Alzheimer’s, ALS, cancer, cachexia, Crohn’s disease, epilepsy, multiple sclerosis, PTSD, autism, pain lasting more than two weeks with severe impact, and others.
Anything else notable: Utah’s “pharmacy” model, EVS card system, and program focus on noncombustible forms remain central features.
Year legalized: 2004.
Year first dispensary opened: 2013.
Possession limits: generally 2 ounces and home cultivation of a small number of mature and immature plants.
Tax rate: no medical-specific retail excise identified.
Qualifying conditions: debilitating-condition list including cancer, HIV/AIDS, multiple sclerosis, severe pain, nausea, seizures, PTSD, Parkinson’s disease, and Crohn’s disease.
Anything else notable: Vermont has long combined a modest but workable home-grow system with patient registration.
Year legalized: 2020 reforms converted Virginia’s limited CBD/THC-A system into a broader medical-cannabis program.
Year first dispensary opened: 2020.
Possession limits: Virginia’s modern medical system is largely practitioner-directed rather than expressed as a single conventional ounce cap.
Tax rate: no medical-specific retail excise was clearly identified in the reviewed materials.
Qualifying conditions: open practitioner discretion; Virginia no longer uses a restrictive list.
Anything else notable: Virginia does not require a traditional patient registry card in the same way many other states do, and delivery has been an important access tool.
Year legalized: 1998, with major clarifying legislation in 2015.
Year first dispensary opened: 2016 under the endorsed medical-retail model inside Washington’s adult-use store network.
Possession limits: registered patients receive higher limits than nonregistered patients and may keep up to 6 plants at home, with provider authorization for more in some cases.
Tax rate: Washington provides sales/use tax exemptions for qualifying registered-patient medical products, though the surrounding cannabis system retains the state’s heavy tax structure.
Qualifying conditions: debilitating-condition model with clinician authorization for terminal or debilitating conditions.
Anything else notable: Washington’s medical market is deeply integrated into the adult-use retail framework rather than operating as a fully separate dispensary network.
Year legalized: 2017.
Year first dispensary opened: 2021.
Possession limits: West Virginia uses a 30-day supply framework; home cultivation is prohibited.
Tax rate: no medical-specific retail tax was clearly identified in the reviewed materials.
Qualifying conditions: enumerated conditions including cancer, HIV/AIDS, ALS, Parkinson’s disease, multiple sclerosis, neuropathies, Crohn’s disease, PTSD, severe chronic pain, terminal illness, epilepsy, and others.
Anything else notable: MPP identifies West Virginia as one of the slowest states ever to implement a medical-cannabis program after enactment.